Magnesium Sulfate Heptahydrate
Active ingredient
Sold as EPSOM SALTS BP · Magnesium Sulfate in…
- Drug class
- -
- Availability
- Prescription only
- Routes
- Intravenous
- Markets covered
- 2
- Products on record
- 13
- FDA reports (12 mo)
- 625
Overview
Plain-language summary, compiled from the cited regulatory records
Magnesium Sulfate Heptahydrate is an active ingredient used in medications. It is available in a formulation that combines Magnesium Sulfate with 5% Dextrose injection [1].
This medication is approved for specific uses related to pregnancy complications. It is indicated for the prevention of eclampsia in patients who have preeclampsia. Additionally, it is approved for the treatment of seizures in patients with eclampsia and for the prevention of recurrent seizures in these patients [1].
Magnesium Sulfate in 5% Dextrose Injection is one brand name under which this active ingredient is marketed [1]. In the past 12 months, there have been 625 adverse event reports associated with this active ingredient [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 12 | January 30, 2026 |
| US United States | FDA | 1 | April 23, 2026 |
GBUnited Kingdom· MHRA
12 products
Uses
Magnesium sulfate 50% w/v solution is indicated in adults, adolescents and children for: i) the treatment of magnesium deficiency in proven hypomagnesaemia ii) the prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutrition Magnesium sulfate 50% w/v solution is indicated in parturients for; i) the control and prevention of seizures in severe pre-eclampsia ii) the control and prevention of recurrent seizures in eclampsia.
How to take
USUnited States· FDA
1 product
Uses
1 INDICATIONS AND USAGE Magnesium Sulfate in 5% Dextrose Injection is indicated for: • Prevention of eclampsia in patients with preeclampsia • Treatment of seizures and prevention of recurrent seizures in patients with eclampsia Magnesium Sulfate in 5% Dextrose Injection is indicated for ( 1 ): • Prevention of eclampsia in patients with preeclampsia ( 1 ) • Treatment of seizures and prevention of recurrent seizures in patients with eclampsia ( 1 )
How to take
Sources & citations
- [1]MHRA (UK) · PL175890011 · revised December 12, 2025
- [2]FDA DailyMed · 03ebeabb-8386-4a… · revised April 23, 2026 [PDF]
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.